Market Data
Market Cap₹718.64 Cr.
52W High₹365
Current Price₹179.6
52W Low₹155.8
Down from 52W High50.8 %
Face Value₹10
Performance
ROCE-0.8 %
ROE-9.9 %
EPS (TTM)₹1.78
EPS Prev Qtr₹-14.45
EPS Last Year₹0.36
EBITDA Qtr₹27.16 Cr.
Book Value₹191
Financial Health
Debt/Equity0.75
Debt/Profit-7.45
Total Assets₹1,970.15 Cr.
Promoter Holding74.94 %
Earning Power-0.59 %
Valuation
Industry P/E19.54
Price to Book0.94
Price to Sales0.47
Key Metrics
Face Value
₹10
About Heranba Industries Ltd
Chemicals · Agro Chemicals
Heranba Industries Ltd is listed on NSE in the Chemicals / Agro Chemicals sector. Face value ₹10. Market cap ₹718.64 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a relatively low P/B ratio of 0.78, indicating it may be undervalued relative to its book value.
- The promoter holding is high at 74.94%, suggesting strong control and potential alignment of interests.
Weaknesses
- The company is currently operating at a loss with a net profit of ₹-76.87 Cr.
- The P/E ratio is negative at -9.09, indicating the company is not profitable and cannot calculate a meaningful earnings multiple.
- Return on Capital Employed (ROCE) is negative at -0.9%, showing poor efficiency in generating returns from capital.
- Return on Equity (ROE) is negative at -9.14%, reflecting poor performance in generating returns for shareholders.
- The company has a Debt to Equity ratio of 0.41, indicating a moderate level of financial leverage which could pose risks if earnings remain weak.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| UPL Ltd | - | 22.74 | ₹46,323.79 Cr | 1.09% | ₹2,323 Cr | - | ₹52,804 Cr | - | 11.43% | 0.64 |
| P I Industries Ltd | - | 30.5 | ₹35,539.97 Cr | 0.64% | ₹1,165 Cr | - | ₹6,515.5 Cr | - | 13.35% | 0.02 |
| Sumitomo Chemical India Ltd | - | 37.32 | ₹21,625.49 Cr | 0.3% | ₹579.39 Cr | - | ₹3,244.89 Cr | - | 23.1% | 0 |
| Bayer CropScience Ltd | - | 341.91 | ₹16,503.41 Cr | - | ₹35.06 Cr | - | ₹1,126.38 Cr | - | 3.26% | 0 |
| Sharda Cropchem Ltd | - | 10.51 | ₹6,578.88 Cr | 2.06% | ₹626.21 Cr | - | ₹5,356.54 Cr | - | 25.75% | 0 |
| Dhanuka Agritech Ltd | - | 14.56 | ₹4,253.44 Cr | 0.21% | ₹296.96 Cr | - | ₹2,035.15 Cr | - | 27.49% | 0.03 |
| Rallis India Ltd | - | 23.7 | ₹3,884.52 Cr | 1.5% | ₹164.2 Cr | - | ₹2,603.93 Cr | - | 12.95% | 0.03 |
| NACL Industries Ltd | - | 273.2 | ₹3,199.76 Cr | - | ₹12.37 Cr | - | ₹1,519.43 Cr | - | 5.97% | 0.44 |
| Bhagiradha Chemicals & Industries Ltd | - | 113.25 | ₹3,113.35 Cr | 0.06% | ₹27.52 Cr | - | ₹607.19 Cr | - | 6.11% | 0.33 |
| GSP Crop Science Ltd | - | 19.54 | ₹2,233.13 Cr | 0.21% | ₹98.53 Cr | - | ₹1,526.11 Cr | - | 22.52% | 0.66 |
| Insecticides India Ltd | - | 13.97 | ₹1,748.63 Cr | 0.33% | ₹125.18 Cr | - | ₹2,060.4 Cr | - | 13.62% | 0.12 |
| Bharat Rasayan Ltd | - | 7.66 | ₹1,737.48 Cr | 0.05% | ₹143.29 Cr | - | ₹1,202.6 Cr | - | 15.11% | 0 |
| Astec Lifesciences Ltd | - | - | ₹1,585.87 Cr | - | ₹-66.57 Cr | - | ₹440.62 Cr | - | -4.23% | 1.15 |
| India Pesticides Ltd | - | 14.07 | ₹1,514.98 Cr | 0.57% | ₹107.69 Cr | - | ₹1,034 Cr | - | 14.14% | 0.11 |
| Meghmani Organics Ltd | - | 22.49 | ₹1,447.3 Cr | - | ₹64.24 Cr | - | ₹2,103.17 Cr | - | 7.69% | 0.55 |
| Punjab Chemicals & Crop Protection Ltd | - | 19.57 | ₹1,280.17 Cr | 0.29% | ₹65.4 Cr | - | ₹1,057.53 Cr | - | 18.32% | 0.34 |
| Excel Industries Ltd | - | 16.4 | ₹1,170.02 Cr | 1.48% | ₹71.38 Cr | - | ₹1,078.84 Cr | - | 5.54% | 0 |
| Dharmaj Crop Guard Ltd | - | 16.43 | ₹988.57 Cr | - | ₹60.17 Cr | - | ₹1,152.96 Cr | - | 18.92% | 0.29 |
| Advance Agrolife Ltd | - | 14.2 | ₹780.43 Cr | - | ₹48.9 Cr | - | ₹799.55 Cr | - | 40.99% | 0.79 |
| Heranba Industries Ltd | - | - | ₹718.64 Cr | - | ₹-76.87 Cr | - | ₹1,525.76 Cr | - | -0.8% | 0.75 |
Quarterly Results
📊 Jun 2026: Revenue fell 15.3% YoY, Profit grew 11.2% YoY
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 452.43 | 521.71 | 301.37 | 319.48 | 383.2 |
| ↳ QoQ Growth | - | +15.3% | -42.2% | +6.0% | +19.9% |
| Expenses | 442.53 | 498.52 | 314.61 | 368.23 | 356.04 |
| Operating Profit | 9.9 | 23.19 | -13.24 | -48.75 | 27.16 |
| OPM % | 2.19% | 4.44% | -4.39% | -15.26% | 7.09% |
| Other Income | 12.77 | -3.12 | 3.8 | -5.51 | 5.85 |
| Interest | 11.55 | 12.33 | 12.39 | 13.77 | 12.91 |
| Depreciation | 21.34 | 25.65 | 25.67 | 25.47 | 21.94 |
| EBITDA | 31.24 | 48.84 | 12.43 | -23.28 | 49.1 |
| EBITDA Margin % | 6.9% | 9.36% | 4.12% | -7.29% | 12.81% |
| Profit Before Tax | 11.12 | 7.74 | -21.83 | -68.03 | 20.1 |
| Tax % | 43.17% | 127.65% | -7.38% | 14.27% | 65.02% |
| Net Profit | 6.32 | -2.14 | -23.44 | -58.32 | 7.03 |
| ↳ QoQ Growth | - | -133.9% | -995.3% | -148.8% | +112.1% |
| EPS | 1.53 | 0.36 | -5.81 | -14.45 | 1.78 |
Profit & Loss
| Mar 2026 | TTM | |
|---|---|---|
| Sales | 1594.99 | 1525.76 |
| Expenses | 1623.89 | 1537.4 |
| Operating Profit | -28.9 | -11.64 |
| OPM % | -1.81% | -0.76% |
| Other Income | 7.94 | 1.02 |
| Interest | 50.04 | 51.4 |
| Depreciation | 98.13 | 98.73 |
| Profit Before Tax | -71 | -62.02 |
| Tax % | -9.27% | -23.94% |
| Net Profit | -77.58 | -76.87 |
| EPS | -18.37 | -18.12 |
Compounded Sales Growth
10Y
-
5Y
-
3Y
-
TTM
-
Compounded Profit Growth
10Y
-
5Y
-
3Y
-
TTM
-
Stock Price CAGR
10Y
-
5Y
-
3Y
-
1Y
-38.57%
Return on Equity
10Y
-
5Y
-
3Y
-
Last Year
-10.09%
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 40.01 | 40.01 |
| Reserves | 800.79 | 721.71 |
| Borrowings | 348.92 | 572.76 |
| Other Liabilities | 623.12 | 635.67 |
| Total Liabilities | 1812.84 | 1970.15 |
| Fixed Assets | 662.32 | 692.38 |
| CWIP | 69.63 | 20.37 |
| Investments | 2.83 | 5.29 |
| Other Assets | 1078.06 | 1252.11 |
| Total Assets | 1812.84 | 1970.15 |
Cash Flows
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from Operating Activity | 101.3 | -95.95 |
| Cash from Investing Activity | -238.87 | -88.91 |
| Cash from Financing Activity | 151.66 | 166.1 |
| Net Cash Flow | 14.09 | -18.76 |
Ratios
| Mar 2026 | |
|---|---|
| Debtor Days | - |
| Inventory Days | - |
| Days Payable | - |
| Cash Conversion Cycle | - |
| Working Capital Days | 319.78 |
| ROCE % | -2.07% |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 74.94% | 74.94% | 74.94% | 74.94% |
| FIIs % | 0.05% | 0.08% | 0.07% | 0.01% |
| DIIs % | 0.27% | 0.27% | 0.27% | 0.29% |
| Public % | 21.07% | 21.1% | 20.66% | 20.92% |
| No. of Shareholders | 70,671 | 69,062 | 67,378 | 66,634 |
Major Shareholders (>1%)
- Raghuram Kanyan ShettyPromoter and Promoter Group29.77%
- Sadashiv Kanyana ShettyPromoter and Promoter Group18.00%
- Sujata Sadashiv ShettyPromoter and Promoter Group8.07%
- Vanita Raghuram ShettyPromoter and Promoter Group5.04%
As of 2026-06-30View all shareholders →